novo nordisk semaglutide pill Wegovy Becomes First Oral GLP-1 Weight-Loss Drug Approved in U.S Novo Nordisk wins EU approval

In a 2023 52-week study of 493 adults, researchers found that compared to people who drank water, those who consumed beverages with non-nutritive sweeteners lost more weight over the study period, an average of 16.5 pounds (7.5 kilograms), compared to those who drank water, who lost an average of 13.4 pounds (6.1 kg)

Lund A, Knop FK, Vilsbll, T

Review prior or active cancer treatments that might increase the risk for CAD (e.g., chest radiotherapy)

Each call rolled to voicemail

SURMOUNT-5 Trial Design and Participants The SURMOUNT-5 study was a 72-week, multi-center, randomized, open-label Phase 3b clinical trial involving 751 participants across the United States and Puerto Rico